Celularity Inc Asset Turnover Ratio (CELU), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Celularity Inc   (NASDAQ: CELU)
 

Celularity Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Celularity Inc 's asset turnover ratio, the ratio that measures the ability of Celularity Inc 's assets to generate revenue, sequentially decreased to 0.22 in the fourth quarter (Dec 31 2025), which does not come as a surprise, as the Celularity Inc continue to experience difficult business climate.

Within sector 185 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 2354 to 3820.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELU Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change -19.11 % -9.82 % -11.23 % -10.39 % -7.79 %
Y / Y Revenue Change -77.37 % -43.16 % -52.64 % -22.17 % 49.7 %
Asset Turnover Ratio (TTM) 0.22 0.33 0.35 0.39 0.4
CELU's Total Ranking # 3820 # 2354 # 2246 # 2677 # 2958
Seq. Asset Change -7.63 % -3.4 % -6.67 % -2.87 % 2.98 %
Seq. Revenue Change -22.33 % -7.88 % -49.8 % -36.98 % 95.05 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 186
Healthcare Sector # 540
Overall Market # 3820

Asset Turnover Ratio Statistics
High Average Low
71.02 10.81 2.83
(Jun 30 2021)   (Dec 31 2025)




CELU Company Profile • Back to CELU Efficiency Comparisons • Compare CELU Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Inotiv Inc   0.68 $ 514.027  Millions$ 757.788  Millions
Akebia Therapeutics Inc   0.68 $ 236.196  Millions$ 349.124  Millions
Strata Critical Medical Inc   0.67 $ 197.126  Millions$ 292.255  Millions
Phathom Pharmaceuticals Inc   0.67 $ 175.110  Millions$ 260.967  Millions
Dexcom Inc   0.67 $ 4,661.900  Millions$ 6,979.650  Millions
Resmed Inc   0.67 $ 5,365.020  Millions$ 8,055.989  Millions
Protalix Biotherapeutics inc   0.67 $ 52.744  Millions$ 79.247  Millions
Ss Innovations International Inc  0.66 $ 47.158  Millions$ 70.940  Millions
Lifestance Health Group Inc   0.66 $ 1,424.285  Millions$ 2,151.095  Millions
Mannkind Corporation  0.66 $ 348.966  Millions$ 527.165  Millions
Koninklijke Philips Nv  0.66 $ 19,974.080  Millions$ 30,177.280  Millions
Guardant Health Inc   0.66 $ 982.021  Millions$ 1,491.668  Millions
Waters Corporation  0.66 $ 3,165.286  Millions$ 4,812.191  Millions
Burning Rock Biotech Limited  0.66 $ 77.157  Millions$ 117.312  Millions
U S Physical Therapy Inc  0.66 $ 780.990  Millions$ 1,189.892  Millions
Avanos Medical Inc   0.65 $ 698.800  Millions$ 1,072.050  Millions
3m Company  0.65 $ 24,948.000  Millions$ 38,321.000  Millions
Align Technology inc   0.65 $ 4,034.013  Millions$ 6,197.290  Millions
10x Genomics Inc   0.65 $ 641.881  Millions$ 988.022  Millions
Sol gel Technologies Ltd   0.65 $ 19.388  Millions$ 29.917  Millions
Scientific Industries Inc   0.65 $ 7.767  Millions$ 11.990  Millions
Transmedics Group Inc   0.65 $ 605.494  Millions$ 935.614  Millions
Alkermes Plc   0.65 $ 1,475.899  Millions$ 2,287.823  Millions
Ani Pharmaceuticals Inc  0.64 $ 883.366  Millions$ 1,370.990  Millions
Neuraxis Inc   0.64 $ 3.569  Millions$ 5.575  Millions
Zoetis Inc   0.64 $ 9,467.000  Millions$ 14,800.750  Millions
Ptc Therapeutics inc   0.64 $ 1,730.655  Millions$ 2,708.002  Millions
Pulmonx Corporation  0.64 $ 90.139  Millions$ 141.374  Millions
Anaptysbio Inc   0.64 $ 234.603  Millions$ 368.699  Millions
Heron Therapeutics Inc   0.64 $ 154.557  Millions$ 243.167  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.